Icon Plc
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ICLR Company Description
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
ICLR Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ICLR Smart Score
Score Breakdown
ICLR Company Description
Show More
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ICLR by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ICLR's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on ICLR's company Twitter account
WallStreetBets
Number of mentions of ICLR in WallStreetBets Daily Discussion
ICLR News
Recent insights relating to ICLR
CNBC Recommendations
Recent picks made for ICLR stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ICLR
Corporate Flights
Flights by private jets registered to ICLR
Our Analysis